Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Long-Term Investments: 2010-2025

Historic Long-Term Investments for BIO-TECHNE (TECH) over the last 10 years, with Sep 2025 value amounting to $234.9 million.

  • BIO-TECHNE's Long-Term Investments fell 2.65% to $234.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $234.9 million, marking a year-over-year decrease of 2.65%. This contributed to the annual value of $236.0 million for FY2025, which is 2.62% down from last year.
  • Per BIO-TECHNE's latest filing, its Long-Term Investments stood at $234.9 million for Q3 2025, which was down 0.45% from $236.0 million recorded in Q2 2025.
  • BIO-TECHNE's Long-Term Investments' 5-year high stood at $257.0 million during Q1 2023, with a 5-year trough of $25.0 million in Q2 2022.
  • For the 3-year period, BIO-TECHNE's Long-Term Investments averaged around $245.2 million, with its median value being $242.3 million (2024).
  • Its Long-Term Investments has fluctuated over the past 5 years, first surged by 923.43% in 2023, then dropped by 5.28% in 2024.
  • Over the past 4 years, BIO-TECHNE's Long-Term Investments (Quarterly) stood at $25.0 million in 2022, then soared by 898.92% to $249.7 million in 2023, then dropped by 3.35% to $241.4 million in 2024, then dropped by 2.65% to $234.9 million in 2025.
  • Its last three reported values are $234.9 million in Q3 2025, $236.0 million for Q2 2025, and $239.5 million during Q1 2025.